151 related articles for article (PubMed ID: 18261173)
1. Aggressive cutaneous squamous cell carcinoma associated with prolonged voriconazole therapy in a renal transplant patient.
Vanacker A; Fabré G; Van Dorpe J; Peetermans WE; Maes B
Am J Transplant; 2008 Apr; 8(4):877-80. PubMed ID: 18261173
[TBL] [Abstract][Full Text] [Related]
2. Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole.
Cowen EW; Nguyen JC; Miller DD; McShane D; Arron ST; Prose NS; Turner ML; Fox LP
J Am Acad Dermatol; 2010 Jan; 62(1):31-37. PubMed ID: 19896749
[TBL] [Abstract][Full Text] [Related]
3. Increased incidence of cutaneous squamous cell carcinoma in lung transplant recipients taking long-term voriconazole.
Feist A; Lee R; Osborne S; Lane J; Yung G
J Heart Lung Transplant; 2012 Nov; 31(11):1177-81. PubMed ID: 22841559
[TBL] [Abstract][Full Text] [Related]
4. High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients.
Singer JP; Boker A; Metchnikoff C; Binstock M; Boettger R; Golden JA; Glidden DV; Arron ST
J Heart Lung Transplant; 2012 Jul; 31(7):694-9. PubMed ID: 22484291
[TBL] [Abstract][Full Text] [Related]
5. Catastrophic squamous cell carcinoma in lung transplant patients treated with voriconazole.
Ibrahim SF; Singer JP; Arron ST
Dermatol Surg; 2010 Nov; 36(11):1752-5. PubMed ID: 20533939
[No Abstract] [Full Text] [Related]
6. Severe photosensitivity causing multifocal squamous cell carcinomas secondary to prolonged voriconazole therapy.
McCarthy KL; Playford EG; Looke DF; Whitby M
Clin Infect Dis; 2007 Mar; 44(5):e55-6. PubMed ID: 17278050
[TBL] [Abstract][Full Text] [Related]
7. Multiple aggressive squamous cell carcinomas associated with prolonged voriconazole therapy in four immunocompromised patients.
Epaulard O; Saint-Raymond C; Villier C; Charles J; Roch N; Beani JC; Leccia MT
Clin Microbiol Infect; 2010 Sep; 16(9):1362-4. PubMed ID: 19930272
[TBL] [Abstract][Full Text] [Related]
8. Phototoxicity and photocarcinogenesis associated with voriconazole.
Epaulard O; Leccia MT; Blanche S; Chosidow O; Mamzer-Bruneel MF; Ravaud P; Thiebaut A; Villier C; Lortholary O
Med Mal Infect; 2011 Dec; 41(12):639-45. PubMed ID: 22055586
[TBL] [Abstract][Full Text] [Related]
9. [Painful peripheral neuropathy associated with voriconazole during the treatment of chronic cavitary pulmonary aspergillosis].
Gendrot A; de La Blanchardière A; de La Gastine B; Fromager G; Massias L; Verdon R
Rev Med Interne; 2010 Feb; 31(2):163-6. PubMed ID: 19457596
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous squamous cell carcinoma in two pediatric lung transplant patients on prolonged voriconazole treatment.
Wong JY; Kuzel P; Mullen J; Lien D; Mahmood M; Conrad C; Fiorillo L
Pediatr Transplant; 2014 Sep; 18(6):E200-7. PubMed ID: 25039541
[TBL] [Abstract][Full Text] [Related]
11. A multistep voriconazole-related phototoxic pathway may lead to skin carcinoma: results from a French nationwide study.
Epaulard O; Villier C; Ravaud P; Chosidow O; Blanche S; Mamzer-Bruneel MF; Thiébaut A; Leccia MT; Lortholary O
Clin Infect Dis; 2013 Dec; 57(12):e182-8. PubMed ID: 24046296
[TBL] [Abstract][Full Text] [Related]
12. Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children.
Walsh TJ; Lutsar I; Driscoll T; Dupont B; Roden M; Ghahramani P; Hodges M; Groll AH; Perfect JR
Pediatr Infect Dis J; 2002 Mar; 21(3):240-8. PubMed ID: 12005089
[TBL] [Abstract][Full Text] [Related]
13. [Careful: skins cancers and voriconazole].
Schmutz JL; Trechot P
Ann Dermatol Venereol; 2011 Nov; 138(11):805-6. PubMed ID: 22078051
[No Abstract] [Full Text] [Related]
14. Voriconazole Exposure and Risk of Cutaneous Squamous Cell Carcinoma, Aspergillus Colonization, Invasive Aspergillosis and Death in Lung Transplant Recipients.
Mansh M; Binstock M; Williams K; Hafeez F; Kim J; Glidden D; Boettger R; Hays S; Kukreja J; Golden J; Asgari MM; Chin-Hong P; Singer JP; Arron ST
Am J Transplant; 2016 Jan; 16(1):262-70. PubMed ID: 26372838
[TBL] [Abstract][Full Text] [Related]
15. Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States.
D'Arcy ME; Pfeiffer RM; Rivera DR; Hess GP; Cahoon EK; Arron ST; Brownell I; Cowen EW; Israni AK; Triplette MA; Yanik EL; Engels EA
JAMA Dermatol; 2020 Jul; 156(7):772-779. PubMed ID: 32401271
[TBL] [Abstract][Full Text] [Related]
16. Multifocal squamous cell carcinomas in an HIV-infected patient with a long-term voriconazole therapy.
Brunel AS; Fraisse T; Lechiche C; Pinzani V; Mauboussin JM; Sotto A
AIDS; 2008 Apr; 22(7):905-6. PubMed ID: 18427212
[No Abstract] [Full Text] [Related]
17. Voriconazole exposure and geographic location are independent risk factors for squamous cell carcinoma of the skin among lung transplant recipients.
Vadnerkar A; Nguyen MH; Mitsani D; Crespo M; Pilewski J; Toyoda Y; Bermudez C; Kwak EJ; Silveira FP; Clancy CJ
J Heart Lung Transplant; 2010 Nov; 29(11):1240-4. PubMed ID: 20591690
[TBL] [Abstract][Full Text] [Related]
18. Lung transplant recipients receiving voriconazole and skin squamous cell carcinoma risk in Australia.
Neoh CF; Snell GI; Levvey B; Kotsimbos T; Morrissey O; Slavin MA; Stewart K; Kong DC
Med J Aust; 2014 Nov; 201(9):543-4. PubMed ID: 25358582
[No Abstract] [Full Text] [Related]
19. Voriconazole-associated myositis.
Shanmugam VK; Matsumoto C; Pien E; Rosen J; Kumar P; Whelton S; Steen V
J Clin Rheumatol; 2009 Oct; 15(7):350-3. PubMed ID: 20009971
[TBL] [Abstract][Full Text] [Related]
20. The incidence of cutaneous squamous cell carcinoma in patients receiving voriconazole therapy for chronic pulmonary aspergillosis.
Kosmidis C; Mackenzie A; Harris C; Hashad R; Lynch F; Denning DW
Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2233-2237. PubMed ID: 32820348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
